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CHAPTER I
INTRODUCTION
Malaria as a Global Threat
Malaria continues to be a serious threat to human health around the world. Taken from
the World Health Organization’s (WHO) recent World Malaria Report, there were an estimated
212 million cases and 429,000 deaths in 2015. Even with the $2.9 billion dollars pumped into the
fight against malaria, there are still 91 countries and territories where the disease is considered to
be endemic. Around 90% of the cases worldwide occurred in the WHO African Region with the
remaining cases occurring in the WHO South-East Asia and Eastern Mediterranean Region. The
WHO also found that only 30% of the population who is most at risk, children under the age of
5, received an antimalarial drug when testing positive for malaria infection.
The Malaria Parasite, Plasmodium
Malaria is a vector-borne disease that is caused by a protozoan, Apicomplexan parasite of the
genus Plasmodium. There are five known species of Plasmodium that can infect humans: P.
falciparum, P. vivax, P. ovale, P. malariae and P. knowlesi. Of these five species, P. falciparum
is the most prevalent species in Africa, causing the most severe form of the disease, and
consequently producing the highest mortality rates (Miller et al., 2002). P. vivax can also cause
symptoms such as anemia; however, P. vivax is less virulent and not as widespread in the
African region. Most of the Plasmodium species are transmitted by the bite of an infected female
Anopheles mosquito (Oaks et al., 1991).
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When an infected female mosquito takes a blood meal on a person, she injects invasive
sporozoites from her salivary glands. The sporozoites travel through the bloodstream to the liver
where they invade hepatocytes. Within the liver cells and over the course of 5-15 days, the
sporozoites undergo schizogony and develop into tens of thousands of merozoites. The liver
stage schizonts burst and release the merozoites into the bloodstream where they can then infect
erythrocytes and continue reproducing asexually. Inside the erythrocyte, the merozoite continues
to develop within a parasitophorous vacuole membrane (PVM) that consists of the membrane
bilayer of the RBC. Over the course of 24-48 hours, the merozoite develops into a trophozoite
and again undergoes schizogony. The schizont bursts and releases 10-20 merozoites into the
blood where they infect new erythrocytes, continuing a cycle that causes the destruction of more
RBCs and ultimately results in the symptoms that are characteristic of malaria (Miller et al.,
2002) (Figure 1 RIGHT).
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A small subset of the parasite population will exit the asexual blood cycle and commit to
sexual development. Instead of undergoing schizogony, the merozoites will develop into distinct
male and female gametocytes. When a mosquito takes up these gametocytes with a blood meal,
the gametocytes complete sexual reproduction within 15 minutes of entering the mosquito
midgut. The female gametocyte egresses from the RBC and forms a macrogamete while the male
gametocyte undergoes three rounds of DNA replication and releases eight exflagellating
microgametes. The microgametes fertilize the macrogametes to generate a diploid zygote (Figure
1 LEFT).
Still part of the mosquito blood meal, the zygote develops into a motile form, called an
“ookinete,” over the course of the next 18-24 hours (Figure 1 LEFT). The parasite elongates into
a polar, banana shape that enables the ookinete to pass through the blood meal and invade the
epithelial lining of the midgut. The ookinete settles under the basal lamina of the midgut
epithelial wall and undergoes multiple rounds of DNA replication and mitosis. Following a large
scale cytokinesis event, the resulting oocyst contains thousands of haploid sporozoites. After 815 days, the oocyst bursts and releases motile sporozoites that travel to the mosquito salivary
glands. Within the salivary glands, the sporozoites are primed for transmission and will be
injected in to the next host during the mosquito’s next blood meal (Oaks et al. 1991).
As drug-resistant parasite strains and insecticide-resistant mosquitoes are becoming more
prevalent (Tun et al. 2015; WHO, 2010), research has been shifting towards the design of novel
transmission blocking strategies. However, the only current transmission blocking vaccine
candidate shows very little potential for long term protection and only targets one stage of the
complex malaria parasite’s life cycle (Gosling & Seidlein, 2016). As most of the research done
on malaria focuses on development within the human host, very little is known about parasite
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cell biology during mosquito stage development. In an effort to better understand and target
Plasmodium transmission, our lab is currently studying the adaptive mechanisms underlying
parasite survival and development, specifically in the mosquito vector.
The Model Rodent Malaria Parasite, Plasmodium berghei
The murine malaria parasite, Plasmodium berghei, has been established in the research
community as an excellent model system for studying the mosquito stages of Plasmodium
(Sinden, 1978). The P. berghei life cycle and morphological characteristics are comparable to
those of the human parasite, Plasmodium falciparum (Sinden, 1978). The genome organization
and metabolic pathways are also largely conserved between the rodent malaria parasites and the
human malaria parasites (Janse et al., 1994; Janse and Waters, 1995). On top of sharing many
genetic and physical features, P. berghei can easily be used to study Plasmodium within the
mosquito vector. As P. berghei is not infectious to humans, mosquitoes can be safely infected
and studied in the laboratory. Working with mice is also much simpler and carries less ethical
implications than working with humans.
Survival in the Mosquito Midgut
Upon arrival in the mosquito midgut and egress from the protective membrane of the
RBC, Plasmodium becomes vulnerable in the inhospitable environment of the bloodmeal. Here,
the parasite is exposed to an increased pH, a decreased temperature, the mosquito’s own
mounted immune response, digestive enzymes (Alavi et al., 2003), reactive oxygen species
(ROS), reactive nitrogen species (RNS), and a diverse microbial flora (Müller, 2004; Fang,
2004). As a result of these stressors, the mosquito acts as a bottleneck for Plasmodium where
only very few parasites survive (Smith et al. 2014; Wang and Jacobs-Lorena 2013).
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Defense Systems
Within the mosquito midgut, Plasmodium must defend itself from the harsh conditions,
including cytotoxic ROS. Using one of the main antioxidant systems, the thioredoxin system, the
parasite generates an environment in which it can cope with the oxidative stressors (Kanzok et
al., 2000).
Thioredoxins and thioredoxin-like proteins comprise a large superfamily of proteins.
Some of the proteins are ubiquitous redox proteins that play essential roles in many biological
processes, such as the detoxification of reactive oxygen and nitrogen species and the redox
regulation of protein function and signaling (Arner and Holmgren, 2000). Thioredoxins
exchange electrons via the reduction/oxidation of dithiol/disulfide bonds, which maintains their
cellular targets in a reduced state (Arner and Holmgren, 2000).
Within the thioredoxin superfamily, only a few proteins, such as Thioredoxin-1, have
been well characterized (Nakao, 2015). Our lab has been studying the thioredoxin system of
Plasmodium and searching for novel thioredoxin-like proteins that could play a role during
parasite development in the mosquito.
Escape from the Midgut
Plasmodium must escape the midgut to avoid digestion with the rest of the bloodmeal.
The parasite accomplishes this by developing into a polar, motile ookinete (Figure 2). This 18hour transformation enables Plasmodium to traverse the epithelial cell lining of the midgut and
move out of the harsh environment (Oaks et al., 1991). Without the ability to move and invade
the epithelial cells, the parasites would fail to establish infection of the mosquito and would be
digested with the rest of the bloodmeal.

6

A complex network of cytoskeletal organelles and filaments located underneath the
plasma membrane, called the inner membrane complex (IMC), facilitates the polarity and
motility (Baum, 2006). Plasmodium motility is driven by an actin-myosin based motor that is
anchored in the IMC (Baum, 2006). The distinctive shape of the ookinete is maintained by a
twisted lattice of subpellicular microtubules that are associated with the IMC (Baum, 2006).
These subpellicular microtubules are lined with proteins that stabilize and maintain the function
of the microtubules. To date, very little is known about these microtubule associated proteins
(MAPs) in Plasmodium ookinete biology. Some have been studied in the merozoite and
sporozoite invasive stages and are primarily based on studies from related Apicomplexan
parasites, such as Toxoplasma gondii.
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Homology in a Related Apicomplexan Parasite, Toxoplasma gondii
Like Plasmodium, Toxoplasma gondii is a protozoan parasite and is a member of the
phylum Apicomplexa. It is the causative agent of toxoplasmosis in humans. T. gondii replicates
primarily in cats and can also survive in a variety of intermediate warm-blooded hosts, such as
pigs and bird. T. gondii has been previously established as a good model for understanding
Apicomplexan biology (Kim and Weiss, 2004; Baum et al., 2008). However, there are notable
differences between T. gondii and Plasmodium. Plasmodium specifically infects hepatocytes and
the red blood cells of its mammalian hosts, whereas T. gondii invades all nucleated cells and
eventually infects many tissues, including the CNS, muscles, and placenta (Montoya and
Liesenfeld, 2004). Additionally, while T. gondii is transmitted by contaminated food, water,
infected faeces or tissues of warm blooded animals, Plasmodium is transmitted solely by
mosquitoes. Keeping these distinct differences in mind, we can use the studies in T. gondii to a
certain degree to inform our own hypotheses about Plasmodium biology.
Genes of Interest
trxl-1
As one of the major defense systems in Plasmodium, our lab studies the thioredoxin (trx)
system and its potential cellular targets. We previously identified a novel P. berghei
Thioredoxin-like protein, TrxL-1 (David et al., in prep) that is conserved across Apicomplexans
where the closest P. berghei relative is T. gondii (Figure 3A) While the N and C terminus of
TrxL-1 vary across species, there is a notably high level of conservation among the Trx-like
domains (Figure 3B). Our initial biochemical characterization shows that the TrxL-1 protein is
redox active and can interact with the thioredoxin system of Plasmodium in vitro. Despite its
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redox activity, TrxL-1 shows very low levels of ROS reduction and therefore cannot be
classified as an antioxidant enzyme.

Characterization of the expression profile of trxl-1 included RT-qPCR and was carried
out by previous members of our lab (David et al. in prep). Relative transcript levels were
examined in the blood stages and mosquito stages. The RT-qPCR data indicates that the trxl-1
transcript is absent during parasite development in the mouse blood and highly upregulated
during mosquito stage development (Figure 4A).
The data also reveals a 10-fold increase in trxl-1 transcript abundance within the
mosquito midgut when compared to the abundance in culture (Figure 4B). As the highest level
of trxl-1 transcript is observed during ookinete development, this suggests that trxl-1 is involved
in early mosquito stage development.

9

Notably, a recent study found that the T. gondii homolog, TgTrxL-1, is associated with
subpellicular microtubules (Liu et al., 2013). Futhermore, TgTrxL-1 localizes to the
microtubules but does not directly affect microtubule stability. Because of our initial results on
trxl-1 and the findings in T. gondii, I decided to study the Plasmodium trx-l gene in this thesis.
spm-1
In the same T. gondii study described above (Liu et al. 2013), it was found that TgTrxL-1
indirectly interacts with the subpellicular microtubules via other proteins, prominently the
subpellicular microtubule protein-1 TgSPM-1 (Tran et al., 2012). Because of these findings, I
also chose to study the Plasmodium spm-1 gene in this thesis.
Unlike the mosquito specific expression of trxl-1, the expression profile data on spm-1
taken from the Plasmodium genome database, PlasmoDB, shows an increase in transcript level
during gametocytes (Aurrecoechea et al., 2009). Additionally, the SPM-1 protein contains a
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conserved domain, the STOP (Stable Tubule Only Polypeptide) domain (Finn et al., 2017).
STOP proteins have been known to function as MAPs that are involved in the stabilization of
axonemal microtubules by conferring cold resistance (Delphin et al., 2012). An SPM-1 homolog,
called STOP Axonemal protein-1 (SAXO-1), has been found to be involved in flagellum motility
in another vector-borne protozoan parasite, Trypanosoma brucei (Dacheux et al., 2012).
Using the data that our lab has accumulated on trxl-1 together with the published data
from the T. gondii studies on spm-1, I hypothesize that trxl-1 and spm-1 play an important
role in ookinete development, specifically in the stabilization of the subpellicular
microtubule network.
To investigate the cellular functions of trxl-1 and spm-1, I decided to generate gene
knockout (KO) parasite lines. However, most of the methods used to modify the Plasmodium
genome are time-consuming and inefficient (Straimer et al. 2012). At the time that I started my
thesis, the CRISPR/Cas9 system had just been used in P. falciparum (Wagner et al. 2014) and P.
yoelii (Zhang et al., 2014) to specifically edit these parasite genomes. Because of their success, I
decided to adapt the CRISPR/Cas9 system to P. berghei.
CRISPR/Cas9 Genome Editing System
The CRISPR/Cas9 gene editing system has been developed as an efficient technology
that can make precise changes to the genome. It has been successfully used to manipulate the
genome of many organisms (Cong et al. 2013; Mali et al. 2013). It is based on Clustered
Regularly Interspaced Short Palindromic Repeats (CRISPR) that act as a bacterial defense
against invading viruses. CRISPR was transformed into a gene editing technology that can be
used to target any locus of interest in the genome via an RNA-directed endonuclease, Cas9
(Figure 5). The small guide RNA (sgRNA) is co-transcribed and forms a complex with Cas9.
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When the sgRNA aligns with its complement in the genome, Cas9 induces a double strand break
(DSB) in the DNA. This DSB is either repaired with the nonhomologous end joining pathway
(NHEJ) or homology directed repair (HDR).

As this system enables the introduction of efficient, specific changes in any gene, it is an
incredibly powerful and valuable tool for Plasmodium research. CRISPR/Cas9 has been
previously established in other Plasmodium species, including the human parasite P. falciparum
and the rodent parasite P. yoelii. (Wagner et al., 2014; Zhang et al., 2014) As CRISPR/Cas9 has
not been established in the rodent model parasite P. berghei, I am the first to use this system in
this malaria model. In this study, I investigated the function of two novel P. berghei genes via
Cas9-mediated gene knockout.
Thesis Objective
Very little is understood about Plasmodium biology within the mosquito vector. The
objectives of this project were to establish the CRISPR/Cas9 system in Plasmodium berghei and
investigate the function of two novel mosquito specific genes, trxl-1 and spm-1. The results
presented in this thesis shed light on the molecular mechanisms that the malaria parasite utilizes
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to survive in the mosquito and ultimately establish infection of the mosquito. While current
malaria treatment and prevention strategies target the parasite in the human host, these data have
the potential to inform novel transmission blocking strategies in the mosquito vector.

CHAPTER II
MATERIALS AND METHODS
Reagents
All PCR primers, oligos, enzymes, and corresponding enzyme buffers were obtained from
Thermo Fisher Scientific (Waltham, MA).
Amresco; Solon, OH: glycerol, sodium dodecyl sulfate (SDS), tris.
Bioexpress; Kaysville, UT: 10X phosphate buffered saline (PBS), agar, fetal bovine serum
(FBS), nuclease free water, tryptone, urea.
Growcells.com; Irvine, CA: X-Gal Powder.
Lonza; Basel, Switzerland: Nucleofector Kit T.
Molecular Research Center, Inc.; Cincicannati, OH: Tri-Reagent RT.
Open Biosystems; Huntsville, AL: anti-Thioredoxin rabbit serum.
Promega; Madison, WI: dithiothreitol (DTT), JM109 Competent Cells, pGEM-T Easy Vector
System.
Sigma-Aldrich; St. Louis, MO: ethylenediaminetetraacetic acid (EDTA), Giemsa, Heparin
sodium salt, nycodenz, paraformaldehyde, penicillin-streptomycin, phenylhydrazine, proteinase
K, pyrimethamine, RPMI-1640 medium, saponin, triton X-100, tween 20.
Southern Biotech; Birmingham, AL: DAPI Fluoromount-G.
Thermo Fisher Scientific; Waltham, MA: 6X DNA Loading Dye, Alexa Fluor 488 Goat antiRabbit IgG, Alexa Fluor 555 Goat anti-Mouse IgG, ampicillin trihydrate, bovine serum albumin
(BSA), boric acid, dimethyl sulfoxide (DMSO), DreamTaq PCR Master Mix, Ethidium Bromide
Solution, GeneJET Gel Extraction Kit, GeneJET Whole Blood Genomic DNA Purification Mini
Kit, GeneJET PCR Purification Kit, GeneJET Plasmid Miniprep Kit, GeneRuler 1 kb Plus DNA
Ladder, glacial acetic acid, glycine, hydrochloric acid (HCl), isopropyl 𝛽-D-1thiogalactopyranoside (IPTG), methanol, magnesium chloride (MgCl2), potassium phosphate
(KH2PO4), sodium borohydride,
13
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sodium chloride (NaCl), sodium hydroxide (NaOH), sodium phosphate (Na2PO4), TopVision LE
GQ Agarose, yeast extract.
Whatman; Dassel, Germany: Reinforced Nitrocellulose Membrane.
Buffers, Media, and Solutions
10X TBE Electrophoresis Buffer: 108 g Tris base, 55 g boric acid, 40 mL 0.5 M EDTA (pH 8.0),
dH2O to 1L.
Freezing medium (blood stocks) 20% Glycerol: 10 mL glycerol, 5 mL 10X PBS, 35 mL nuclease
free water. Filter sterilize.
Freezing medium (bacterial stocks) 50% Glycerol: 25 mL glycerol, 5 mL 10X PBS, 20 mL
nuclease free water. Filter sterilize.
50X TAE Electrophoresis Buffer: 242 g Tris base, 57.1 mL glacial acetic acid, 100 mL 0.5 M
EDTA (pH 8.0), dH2O to 1L.
Blocking Buffer: 3% BSA in PBST.
Luria-Bertani (LB) Medium: 5 g yeast extract, 10 g NaCl, 10 g tryptone, 1L dH2O. Sterilize by
autoclaving.
Ookinete Culture Medium: RPMI-1640, 20% FBS, 1% pen-strep, pH 8.2. Filter sterilize.
PBST: 1X PBS, 0.1% Tween 20, pH 7.2. Sterilize by autoclaving.
Pyrimethamine Solution (7mg/mL): 70 mg pyrimethamine, 10 mL DMSO. Dissolve
pyrimethamine in DMSO via vortexing. Dilute 100X with tap water for final volume of 1L.
Adjust pH to 3-5. Store at 4 degrees for 7-10 days.
Shizont Culture Medium: RPMI-1640, 20% FBS, 1% pen-strep, pH 7.2. Filter sterilize.
Accession Numbers
Protein Name
Thioredoxin 1 (Trx1)
Thioredoxin Reductase (TrxR)
Thioredoxin-like Protein-1 (TrxL1)
Subpellicular Microtubule Protein 1 (SPM1)
1-Cysteine Peroxiredoxin (1-Cys Prx)
Table 1. Accession numbers for all genes examined.

PlasmoDB Accession Number
PBANKA_1320900
PBANKA_0824700
PBANKA_0820200
PBANKA_0810700
PBANKA_122800
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Ethics statement
All experimental protocols followed the National Institutes of Health guidelines for
animal housing and care and were approved by the Institutional Animal Care and Use Committee
(IACUC) of Loyola University Chicago (Protocol#1429/40).
Parasite Maintenance
Plasmodium berghei ANKA 2.34 wild type (WT) parasites were maintained in outbred
Charles River strain CF1 mice. After a maximum of six passages, the parasites were passed
through Anopheles stephensi mosquitoes and subsequently kept at 19°C, 80% RH, 12 hrs lightdark cycle, 5%glucose solution. On day 17 post infectious blood meal (PIBM), the mosquitoes
were allowed to feed on naïve mice for 15 minutes. The new generation of parasites were
harvested when the mice reached ~30% parasitemia (percent infected RBCs). Blood stocks of P.
berghei parasites were stored at -80°C in 20% glycerol in phosphate-buffered saline (PBS).
Mosquito Maintenance
Anopheles stephensi mosquitoes were reared under standard conditions in the insectary
(26°C, 80% RH, 12 hrs light-dark cycle). The mosquito colony was maintained by allowing one
bucket of at least one week old mosquitoes to feed on mice once a week. Two days post feed, an
egg cup was placed in the bucket where the female mosquitoes lay their eggs and three to six
new pans were set to equilibrate. Three days post feed, eggs from the egg cup were transferred to
the equilibrated pans. Larvae were fed daily until pupation. All mature pupae were transferred to
a new bucket in a small cup. Once the pupae emerged, the mosquitoes were provided with a 5%
glucose feeding solution in a cup with filter paper.
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Exflagellation
The egress and subsequent exflagellation of the male gametocytes is measured in vitro
via live bright field microscopy. 2 uL of infected mouse tail blood is incubated in 2 uL heparin
and 50 uL ookinete culture medium at 19°C for 15 minutes. 10 uL of each sample is added under
the cover slip of a hemocytometer. The number of exflagellating cells are counted per 20X field.
Ookinete Cultures
For the enrichment of gametocytes, mice were pretreated with phenylhydrazine (Phz) 2
days before injecting blood stage parasites. Exflagellation rates were checked 2 days postinfection. The blood was harvested when exflagellation reached >10 exflagellations/20X field.
The blood of infected mice was pooled, diluted 1∶5 with ookinete culture medium (RPMI-1640,
pH 8.2), and incubated at 19°C for 24 hrs.
Infectious Mosquito Feeds
Similar to the ookinete cultures, mice were pretreated with phenylhydrazine (Phz) 2 days
before injecting blood stage parasites. Exflagellation rates were checked 2 days post-infection.
Once the exflagellation reached >10/20X field, female Anopheles stephensi mosquitoes were
allowed to feed on the infected mice for 15 minutes. The bloodfed mosquitoes were subsequently
stored in an environmental chamber kept at 19°C, 80% RH, 12-hour light-dark cycle, 5% glucose
solution.
Isolation and Purification of P. berghei genomic DNA
Genomic DNA (gDNA) was extracted from 200 uL of whole blood of the infected mice.
The GeneJET Whole Blood Genomic DNA Purification Mini Kit was used to perform cell lysis
and subsequent DNA purification. DNA concentration and purity was assessed using the
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FLUOstar Omega plate reader (BMG Labtech; Cary, NC). All gDNA samples were stored at 20°C.
CRISPR/Cas9 design and Plasmid Construction
The TrxL-1 KO and SPM-1 KO plasmids were generated using the plasmid pYC (for
plasmid for yoelli containing Cas9) which was a kind gift from Jing Yuan, Xiamen University,
Xiamen, Fujian, China. The PyU6 promoter driving the sgRNA cassette was replaced with a
Plasmodium berghei specific U6 snRNA promoter (PbU6) that was amplified from P. berghei
ANKA genomic DNA (Primers in Table 2). The P. berghei specific plasmid was named pBC
(plasmid for berghei containing Cas9).
The 20bp target sequence (TS) for each gene of interest was determined using Geneious 8
(https://www.geneious.com, Kearse et al., 2012). The annealed oligonucleotide TS for trxl-1 was
inserted into the BsmBI restriction site. Due to difficulties in the ligation of the trxl-1 TS, the
spm-1 TS was designed into the forward primer of a primer set that amplified the sgRNA using
pBC as the template. The resulting spm-1 TS-sgRNA product was inserted into pBC and
replaced the empty sgRNA scaffold.
For the generation of a targeted and easily detectable gene deletion, a homology template
for Homology Directed Repair (HDR) of each gene of interest was designed in the pCR4-TOPO
TA Vector (a generous gift from Kim Williamson, Uniformed Services University) based on
previously described methods [3]. The 5’ and 3’ genomic regions flanking each gene of interest
were amplified from PbWT genomic DNA and successively inserted on each side of a short
disrupter. The complete 5’UTR-Disrupter-3’UTR homology construct was inserted into the
HindIII restriction site on pBC. The finished TrxL-1 KO plasmid was named pBCT (plasmid for
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berghei containing Cas9 for trxl-1 KO) and the SPM-1 KO plasmid was named pBCS (plasmid
for berghei containing Cas9 for spm-1 KO).
Polymerase Chain Reaction (PCR)
All PCR reactions were incubated on the Eppendorf Mastercycler ep gradient S thermal
cycler. The primers used for the amplification of the PbU6 promoter, TrxL-1 5’ UTR and 3’
UTR, SPM-1 5’ UTR and 3’ UTR, TrxL-1 target sequence, SPM-1 target sequence and guide
RNA, gene disrupter, and sequencing reactions are listed in Table 2.
Target

Fwd

PbU6

P1

TrxL1
5’ UTR
TrxL1
3’ UTR
SPM1
5’ UTR

Primer Sequence 5’ à 3’

Rev

Primer Sequence 5’ à 3’

GGCGCCCTCTACTTCACGCAAA
CATATGTATAACTCGAAGTAT
P2
TGTAACAC
GCGCATATG
GGATCCGCAAGCTTGGATGTGT
GGATCCCCATTTAAACTATTAT
P3
P4
TAAGTGTATTATGGATGGC
GTTC
TCTAGAACATATTTGCCAATGT
TCTAGAGCAAGCTTCTTATACT
P5
P6
GGAGAACG
TTATTTCATCCC
P7

GGATCCGCAAGCTTAACATTTT
ACAGAAATATGCAGC

P8

GGATCCCATCTATGAAAGCCA
CACGT

SPM1
P9 TCTAGACAGCTGAACATATATT P10 TCTAGAGCAAGCTTATACGTG
3’ UTR
TTGGG
CATTTCTTAGCGTTTCC
Sequencing
Homology P11 AATTTCACACAGGAAACAGC P12 GCACAATATCTAGGATACTAC
Constructs
GTTTTTAGTCGTTATCGGAAGT
AAACTCACTTCCGATAACGAC
TrxL1 TS P13
P14
GA
TAA
SPM1 TSTCAGCTGGATAAGTAGGTGCGT
P15
P16 TGACGTCCAAAAAAAGCACC
sgRNA
TTTAGAGCTAGAAATAGCAAG
Gene
P17 GGATCCACTAGTAACGGCCG P18 GCTAGCTACGAAGGGCGAAT
Disrupter
Sequencing
TTGCTAATTTTTTGTGAGCAGA
CAATCGCACATGCACGTATTC
P19
P20
TrxL1
CC
G
Sequencing P21 GACTGTTTATTTTAAAGCACAT P22 GCATAATTCATTCAATCGATTT
SPM1
TG
CC

Table 2. PCR Primers.
All reactions were set up using the general guidelines as follows:
5 uM forward primer,
5 uM reverse primer,
750 ng gDNA template,
1X DreamTaq PCR Master Mix
Nuclease free water up to a final volume of 20 uL

Amplicon
337 bp
359 bp
361 bp
690 bp
497 bp
--------150 bp
-------------
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All reactions were incubated in the ThermoCycler with the following program:
Initial Denaturing: 10 minutes at 95°C
Denaturing: 30 seconds at 95°C
Annealing: 30 seconds at 56°C - 60°C
Elongation: 30 seconds – 3 min at 72°C

35 Cycles

Final Elongation: 5 minutes at 72°C
The primer annealing temperature was determined first by subtracting 5 degrees from the
melting temperature provided. If the reaction did not work, a gradient was set up to determine
optimal annealing temperature for the primer sets. The elongation time was determined by the
length of the desired PCR product following the convention that the polymerase runs at about 1
kb per minute.
If the gradient did not prove successful, the concentration of magnesium chloride was
increased due to the difficult template. Increasing magnesium chloride concentration improved
the genomic DNA amplification where there is a high AT content.
DNA Electrophoresis
Depending on their size, all DNA fragments were run out on a 0.8% - 1.2% agarose gel
containing 0.5 ug/mL ethidium bromide. If the samples did not already contain loading dye, 6X
DNA loading dye was added to a final concentration of 1X. GeneRuler 1 kb Plus DNA Ladder
was used to determine DNA fragment size. The gel was run in 1X TAE buffer at 110V for 40
minutes using the Owl Horizontal Gel Electrophoresis System (Thermo Fisher Scientific;
Waltham, MA). The DNA bands were visualized under UV light and subsequently extracted
with the GeneJET Gel Extraction Kit.
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TA Cloning of PCR Products into pGEM
The pGEM-T Easy Vector System II was used with the gel extracted PCR products. The
reagents were used in the following concentrations: 1X Rapid Ligation Buffer, 25 ng pGEM-T
Easy Vector, 3 units T4 DNA Ligase, PCR product 3-5 times more concentrated than the vector,
and nuclease free water up to 10 uL. The ligation was incubated overnight at 4°C.
Transformation of JM109 E. coli Competent Cells
2 uL of a ligation mixture was gently mixed with 25 uL of competent cells in a 1.5 mL
microcentrifuge tube. The cell-ligation mixture was incubated on ice for 20 minutes. The cells
were heat shocked at 42°C for 45 seconds and placed on ice for 2 minutes. 275 uL of LB
medium was added to the cells and incubated in a shaking incubator at 37°C for 1 hour. The
resulting transformed cells were spread on pre-warmed LB/agar plates containing 0.1 mg/mL
ampicillin.
If transforming a pGEM ligation, blue/white screening was also used. Before addition of
the transformed cells, 0.1 mM IPTG and 20 ug/mL X-Gal was spread onto the LB/agar plates
and allowed to absorb. Once the cells soaked into the plate, the plate was inverted and incubated
at 37°C overnight.
Restriction Digests
Restriction digests for each desired fragment were set up using the enzymes listed in
Table 3. The reactions were set up according to the manufacturer’s instructions using each
enzyme’s recommended buffer. The digests were incubated for at least 2 hours (up to overnight)
at 37°C and subsequently run out on a 0.8% - 1.2% agarose gel. If a fragment was to be inserted
into a vector, the digested vector was dephosphorylated using a Calf Intestinal Alkaline
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Phosphatase (CIAP) before running the sample on the gel. The correctly sized DNA fragments
were cut out and purified via gel extraction.
Primer Set

Forward

Reverse

Fragment Size

PbU6

KasI

NdeI

337 bp

TrxL1 5’ UTR

BamHI, HindIII

BamHI

359 bp

TrxL1 3’ UTR

XbaI

XbaI, HindIII

361 bp

SPM1 5’ UTR

BamHI, HindIII

BamHI

690 bp

SPM1 3’ UTR

XbaI

XbaI, HindIII

497 bp

SPM1 TS-sgRNA

NdeI

AatII

150 bp

Table 3. Restriction Enzymes.
Ligations of DNA Fragments into a Vector
Ligations into vectors other than pGEM were set up using 1X T4 DNA Ligase Buffer, 1
unit T4 DNA ligase, and varying ratios of insert to vector where there was always at least 2X
more insert than vector. The reaction was incubated at room temperature for 2 hours or overnight
at 4°C.
DNA Isolation, Purification, and Concentration
Precultures with transformed bacterial colonies were set up with 1 colony in 5 mL LB
medium and 5 uL of 100 mg/mL ampicillin. The precultures were incubated overnight in a 37°C
shaker and pelleted the following day. Plasmids were isolated from the bacteria and purified
using the GeneJET Plasmid Miniprep Kit. If necessary, the plasmid DNA was precipitated and
concentrated using ethanol. 0.1 volumes of 3M sodium acetate and 3 volumes of ice cold 100%
ethanol was added to the DNA and mixed via vortexing. The DNA was allowed to precipitate for
at least 1 hour at -20°C and pelleted at 13000 rpm at 4°C for 30 minutes. The pellet was washed
twice with 500 uL ice cold ethanol and spun down at 4°C for 10 minutes after each wash. The
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ethanol was carefully removed and allowed to dry. The pellet was resuspended in an appropriate
volume of nuclease free water.
Generation of Transgenic Parasites
All transgenic parasite lines were generated from Plasmodium berghei ANKA wild type
(PbWT) parasites. Each plasmid (pBC, pBCT, and pBCS) was transfected following previously
described methods (Janse et al., 2006).
Schizont Culture and Purification
A naïve mouse was infected with PbWT parasites from a frozen blood stock. The
infected mouse was then exsanguinated and passed into 2-4 new mice. When the mice reached a
parasitemia of 1-3%, they were exsanguinated and the blood was added to 10 mL of schizont
culture medium supplemented with heparin. The blood was spun down at 500xg slowly and the
supernatant was discarded. The blood was resuspended in fresh schizont culture medium and
transferred to tissue culture flasks. The cultures were incubated overnight at 37°C with 5% CO2
and 3% O2.
The cultures were harvested when around 80% of the schizonts were mature with 8-14
merozoites per cell. The blood was gently layered on top of a 17% Nycodenz layer and
centrifuged slowly at 500xg for 20 minutes. The interface between the layers that contains the
mature schizonts was collected with a Pasteur pipet, transferred to a fresh tube, and
supplemented with fresh culture medium. The collected schizonts were again centrifuged at
500xg for 10 minutes. The supernatant was removed, and the pellet was resuspended in enough
media to aliquot 1 mL of resuspended schizonts per 1 injection. The aliquoted schizonts were
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briefly centrifuged for 5 seconds at 17,000xg. The supernatant was removed and the pellet was
immediately used for transfection.
Transfection of P. berghei
The plasmids were transfected into P. berghei schizonts using the Nucleofector kit T
(VCA-1002; Lonza, MD). 80 uL of the Nucleofector Solution and 20 uL of the Nucleofector
Supplement were added to 10 uL of linearized plasmid DNA at a concentration of .5 - 1 ug/uL.
100 uL of the DNA mixture was used to resuspend 1 pellet of aliquoted schizonts. This cell
suspension was quickly transferred to an electroporation cuvette and inserted into the Amaxa
Nucleofector I Electroporator (Amaxa Biosystems; Cologne, Germany). Electroporation was
carried out using program U33.
Immediately following electroporation, the cells were supplemented with 50 uL of fresh
pre-warmed schizont culture medium. The 150 uL of transfected cells was then directly injected
into the tail vein of naïve mice using an insulin syringe. The mice were positioned under a heat
lamp 5-10 minutes prior to injection in order to increase the size and visibility of the veins in the
mouse tail.
Drug Selection
The transfected constructs all contain a pyrimethamine resistance gene, dhfr. In order to
select for the transgenic parasites, pyrimethamine was added to the drinking water 1 day after the
injections. Around 8-10 days post injection, the pyrimethamine-resistant parasites could be
visualized in the blood. The blood containing transgenic parasites was harvested and the genomic
DNA was extracted.
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Verification of Gene Knockout
CRISPR/Cas9 mediated gene deletion was verified via PCR using specific primers up
and downstream of the genomic region coding for each gene. The primers were located outside
of the region amplified for the generation of the homology construct on the plasmids to ensure
that there was no cross reactivity with the transfected plasmid.
Parasite Cloning
PCR verified KO parasites were passed into naïve mice for cloning. 2 uL of tail blood
from the infected mice was diluted so that 1 parasite was injected intravenously into 6 naive
mice. The cloned parasite lines were then used in all subsequent experiments and analyses.
Growth Curves
Blood Stages
For the analysis of growth in the blood stages, a predetermined number of parasites were
injected directly into the tail vein of naïve mice. After the injection, the mice were monitored
daily with blood smears. The blood was taken from a tail snip, smeared, fixed with methanol,
and stained with Giemsa. The parasitemia was measured daily until the mice showed signs of
illness. The mice were then exsanguinated and the blood was stored at -80°C.
Mosquito Stages
In order to assess ookinete development in vitro, ookinete cultures were set up. At 12, 18,
and 24 hours post culture set up, samples of the cultures were smeared, fixed with methanol,
Giemsa-stained, and visualized with light microscopy at 100X magnification. The ookinetes
were classified as either mature or immature based on the level of development for each time
point.
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In order to assess ookinete development in vivo, infectious mosquito feeds were set up.
At 12, 18, and 24 hours post infectious blood meal (PIBM), bloodfed mosquito midguts were
dissected. Each midgut was resuspended in 5 𝜇L of PBS and smeared on a slide. Each slide was
fixed in methanol, stained with Giemsa, and visualized with light microscopy at 100X
magnification. The ookinetes were classified as either mature or immature based on the level of
development for each time point.
Sampling and Fixation of Parasites
Blood stage parasites were isolated from tail vein blood from mice and were resuspended
in RPMI-1640 pH 7.4 media with heparin pre-warmed to 37°C and allowed to adhere to 0.01%
poly-L-lysine coated glass slides at 37°C. Gametogenesis was induced by resuspending tail
blood in RPMI-1640 pH 8.2 media with heparin pre-warmed to 19°C and allowed to adhere to
0.01% poly-L-lysine coated glass slides at 19°C. Cells were then fixed in 3% paraformaldehyde
with 0.1% glutaraldehyde at 4°C. Cultured ookinetes were taken at experimental time points 12,
18, and 24 hours post culture setup. RBCs were lysed with 0.17 M NH4Cl. Cells were then
resuspended in 0.05 M Tris 0.9% NaCl pH 8.2 and allowed to adhere to 0.01% poly-L-lysine
coated glass slides. Cells were then fixed in 4% paraformaldehyde at 4°C. Midgut ookinetes
were isolated from dissected midguts by crushing midguts with mortar and pestle in 0.05 M Tris
0.9% NaCl pH 8.2 and allowed to adhere to 0.01% poly-L-lysine coated glass slides.
Immunofluorescence Labeling
All steps were carried out at room temperature unless stated otherwise. Prepared slides
were permeabilized with 0.1% Triton-X and blocked with 3% Bovine Serum Albumin (BSA) in
PBS containing 0.1% Tween-20 (PBST). Slides were incubated overnight at 4°C with rabbit
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polyclonal anti-sera containing anti-PbTrx-1 antibodies (diluted 1:500 in blocking buffer) and
mouse monoclonal antisera containing anti-𝛼-tubulin antibodies (diluted 1:2000). Slides were
then incubated for 1 hour with goat anti-rabbit or anti-mouse IgG Alexa Fluor 488 or 555,
respectively, (generous gifts from Dr. Tom Sanger and Dr. Jennifer Mierisch, Loyola University
Chicago) diluted 1:1000 with blocking buffer. Slides were sealed with glass cover slips in DAPI
mounting medium.
Sequence Alignments
Geneious v8 (Kearse et al., 2012) was used to compile all sequences that were aligned.
The alignments were performed via MUSCLE within the Geneious software. The protein
sequence features were determined using the InterPro database (Mulder et al., 2005).
Statistical Analysis
For the blood stage growth curves, statistically significant differences were determined
using independent t-tests using GraphPad Prism version 7 for Mac, GraphPad Software, La Jolla
California USA www.graphpad.com. For the mosquito stage growth curves, statistically
significant differences were determined using independent t-tests using R version 3.3.1 Vienna,
Austria http://www.R-project.org. The level of development (mature vs. immature) of the WT
and TrxL1 KO ookinetes were compared at each time point.

CHAPTER III
RESULTS
Establishing the CRISPR/Cas9 System in Plasmodium berghei
In order to successfully establish and utilize the CRISPR/Cas9 system in P. berghei, I
created a new protocol using online resources and previous literature as a guide (Wagner et al.
2014; Zhang et al. 2014; Addgene.org). I studied the CRISPR information available on the
nonprofit plasmid repository, Addgene, to learn how to adapt the CRISPR/Cas9 technology to P.
berghei. To generate an effective working protocol and inform my experimental design, I
specifically used Addgene’s CRISPR tools, such as the CRISPR guide and the CRISPR 101
eBook.
Generation of the CRISPR/Cas9 Specific Plasmid
As researchers had recently established the CRISPR/Cas9 system in P. falciparum
(Wagner et al. 2014) and P. yoelii (Zhang et al. 2014), I investigated the possibility of using their
constructs as templates. The establishment of CRISPR in P. falciparum required the cotransfection of two plasmids, one containing the Cas9 construct, and the other containing the
replacement cassette for the target gene (Wagner et al., 2014). This significantly decreases the
efficiency of transfection and production of transgenic parasites. In contrast, the P. yoelii plasmid
pYC contains all of the necessary CRISPR/Cas9 components on one large plasmid (Figure 6)
(Zhang et al., 2014). pYC is comprised of a strong constitutive P. berghei elongation factor 1
alpha promoter (Pbef1⍺ ) that drives the expression of the CRISPR-associated endonuclease
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(Cas9) gene as well as a P. yoelii U6 small nuclear RNA promoter (PyU6) that drives the
expression of the single guide RNA (sgRNA) scaffold. pYC also contained two drug resistance
genes, an ampicillin resistance gene for plasmid selection in E. coli and a pyrimethamine
resistance gene for selection of transgenic parasites. Because pYC was shown to be successful in
establishing CRISPR in P. yoelii (Zhang et al. 2014) and only required the transfection of one
construct, I decided to use pYC as my template. Following an inquiry with Dr. Jing Yuan from
the Xiamen University in Xiamen, China, I received pYC as a generous gift.

To make the CRISPR plasmid specific to P. berghei, I first needed to replace the P. yoelii
U6 promotor with the homologous P. berghei U6 promoter. Using the BLAST sequence
alignment too (Altshul et al. 1990), I searched the P. berghei genome for similar RNA promoters
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and found an annotated P. berghei U6 spliceosomal RNA homolog (Otto et al., 2014). To clone
the promoter (PbU6), I designed primers and amplified a 340 bp segment upstream of the
transcription start site of the U6 homolog. Following sequence verification, I replaced PyU6 in
pYC with the PbU6 to function as the new P. berghei specific promoter. I named the resulting
plasmid, pBC (plasmid for P. berghei CRISPR/Cas9), which was used for all future
modifications described herein.

The next step was to modify pBC to generate a trxl-1 knockout plasmid. I first identified
a 20 bp target sequence (TS) within the trxl-1 gene (Figure 7) that ended with a PAM sequence
of 5’ NGG 3’. In order to identify the best candidates for the TS, I utilized the ‘Find CRISPR
sites’ function in the sequence analysis software, Geneious v8 (Kearse et al., 2012). It scans the
gene of interest, cross references it to the Plasmodium berghei genome, and scores each 20 bp
sequence with a specified PAM sequence of 5’ NGG 3’. The score is generated based on the
nucleotide composition, type of PAM sequence (TGG is preferred), and the number of potential
off-target sites in the genome. 100% is the maximum CRISPR score possible.
From the scored sequences in the trxl-1 CDS, I chose a TS within exon 3 that resulted in
a CRISPR score of 99.96% (TS location shown in figure 7). The short nature of the TS allowed
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me to design it as two overlapping oligonucleotides with flanking restriction sites. I next
attempted to clone the 20 bp TS into pBC. However, this proved to be inefficient as sequencing
revealed that multiple copies of the TS were inserted sequentially into the plasmid (Figure 8
LEFT).
I repeated the cloning process while varying the concentration of the TS and sequenced
the resulting plasmids. After three rounds of cloning and sequencing, I finally detected one
bacterial colony containing a plasmid with only one copy of the 20 bp TS inserted directly
upstream of the sgRNA (Figure 8 RIGHT). I named the resulting plasmid pBCT (plasmid for P.
berghei CRISPR/Cas9 mediated trxl-1KO).

For an additional level of specificity, I next designed a trxl-1 homology construct to act
as a donor template for the homology directed repair (HDR) of the Cas9-induced double strand
break (DSB) (See Figure 3). I generated the left and right homology arms by cloning 300-500 bp
regions upstream and downstream of the trxl-1 coding region, respectively. In a separate vector, I
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designed the construct around a short, random gene disrupter (IN) where the disrupter sequence
is flanked by the right and left homology arms (Figure 9).

The homology construct was excised and cloned into pBCT, completing my trxl-1KO
CRISPR plasmid. pBCT, contains all of the required machinery to adapt the CRISPR/Cas9
system to Plasmodium berghei and generate a targeted gene knock out of trxl-1.
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A plasmid map detailing all genetic elements of pBCT is shown in Figure 10. I have also
included a simplified schematic demonstrating how pBCT serves as the template during HDR
(Figure 11).

Generation of Transgenic P. berghei
To generate trxl-1KO parasites, pBCT was prepared for transfection. The blood of P.
berghei WT-infected mice was harvested at a 1-3% parasitemia. The parasites were cultured
overnight to allow them to mature into schizonts. The schizonts were harvested using a
Nycodenz density gradient. pBCT was then electroporated into the purified schizonts, which
were immediately injected into the tail veins of naïve mice. On the next day, the antimalarial
drug, pyrimethamine (pyr) was administered in the drinking water of the mice to select for
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transgenic parasites. I observed pyr-resistant transgenic parasites in the blood smears of mice
eight to ten days post transfection. Once the infected mice reached a parasitemia of at least 10%,
they were exsanguinated and the gDNA of the parasites was extracted for verification of trxl-1
gene deletion.
Verification of Cas9-mediated Gene Deletion of trxl-1
For verification, I designed specific reporter primers as indicated in Figure 11 & 12. PCR
analysis was carried out using the following DNA templates: wild type gDNA (WT), four
samples of putative TrxL-1KO gDNA isolated from infected mice (KO1, KO2, KO3, KO4), and
the plasmid pBCT. I also included a no template control (NTC).
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To amplify the trxl-1 locus, primers P1 and P2 were used (Figure 12). They are located
outside of the trxl-1 UTRs so that they recognized the gDNA template but not the homology
construct on pBCT. The calculated amplicon size in the WT gDNA was 2.4 kb and the expected
amplicon size for TrxL-1KO gDNA was calculated to be significantly shorter at 1.1 kb. The PCR
results showed a clear band around 2.4 kb in the WT gDNA showing an unaltered trxl-1 gene. In
contrast, the KO4 gDNA sample showed a band around 1.1 kb indicating successful gene
deletion of trxl-1. My KO1 and KO2 samples did not show any clear bands. The KO3 samples
showed bands around 2.4 kb and 1.1 kb indicating a mixed population of WT and KO parasites.
No amplification occurred in pBCT or NTC confirming that there was no cross-reactivity with
the plasmid or contamination of my primers, respectively.
In addition, I checked for HDR-specific gene deletion (Figure 12). Primers P3 and P4
were designed to hybridize with the gene disrupter sequence (IN). The primer combinations,
P1+P4 and P2+P3, can only amplify a product if the gene disrupter within the homology
construct was integrated into the genome replacing the trxl-1 gene. The expected amplicon size
for P1+P4 was 500 bp and for P2+P3, it was 700 bp. For each of the TrxL-1KO gDNA samples,
the PCR resulted in the expected bands for both of the primer sets. Concomitantly, these primer
combinations did not produce bands in the WT gDNA, pBCT or NTC samples. Notably, the
KO1 and KO2 samples contained the recombinant locus, even though there was no detectable
amplification with the P1+P2 primer combination. The reason behind this is unclear.
To control for the integrity of all gDNA samples as well as the consistency of my
preparation, I used primers specific to the 1-cys prx gene (gDNA control), a single copy gene
previously characterized in our lab (Turturice et al. 2013). The expected amplicon size was 1.0
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kb. All PCR controls reactions resulted in the amplification of the expected 1.0 kb sized band in
all gDNA samples while no amplification in pBCT or NTC sampes occurred (Figure 12).
The gDNA from the transgenic KO3 parasite population was the only sample producing
the bands that correspond to the size of the trxl-1 gene deletion, recombination via HDR, and no
amplification of the WT locus. I therefore chose to generate clonal lines from the transgenic KO3
sample.
Generation of Clonal Parasite Lines
Parasite cloning is used to generate a population of genetically identical parasites. To this
end, a sample of parasites from a mixed population will be serially diluted so that only a single
parasite will be injected into the tail vein of a naïve mouse. I decided to use the KO3 population
for parasite cloning since my PCR showed complete deletion of trxl-1. In my first attempt, I
calculated for the injection of a single parasite directly into each of the tail veins of ten mice.
After these attempts using one parasite per injection did not result in mouse infection, I increased
the number to two parasites per injection. As a result, two out of ten of the mice that I injected
showed blood stage parasites ten days post tail injection. These clones are herein referred to as
clone 1 (c1) and clone 2 (c2).
I extracted the genomic DNA from each of the clonal lines for verification of gene
deletion. After initial passage, clone 1 would not increase past 5% parasitemia. With such low
infection rates, I could not verify gene deletion and continue with this clonal line. I have stored
c1 at -80C for later analysis. Clone 2 was able to reach a higher parasitemia of around 35%, and I
was able to verify gene deletion via PCR. For my thesis, I used c2, referred to as the TrxL-1KO
line, for all subsequent phenotypic analyses.
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Analysis of TrxL-1KO Parasites
I investigated the potential phenotype of the TrxL-1KO parasites utilizing the following
methods. I first compared the growth rate of the TrxL-1KO clonal line to that of its parental WT
strain during blood stage development. Second, I examined parasite development during the
mosquito stages. I simultaneously assessed parasite morphology via light microscopy and
immunofluorescence microscopy.
Trxl-1 is Not Essential in Blood Stage Development

To determine whether a phenotype was present in asexual stages, 2,000 parasites of WT
and TrxL-1KO were each injected into the tail vein of a naïve mouse. For each experiment, I
injected three mice with WT and three mice with TrxL-1KO parasites. The parasitemia was
measured daily by counting the number of infected red blood cells.
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The data was compiled and the mean parasitemia over time was plotted for the WT and TrxL1KO (Figure 13).
The growth curve indicated that both TrxL-1KO and WT parasites were visible in the
blood smears by day five. The mice infected with WT began to show symptoms such as ruffled
fur, lethargy, pale eyes, and respiratory distress, around day eight or day nine with parasitemia
ranging from 10-15%. In contrast, the TrxL-1KO parasites seemed to show much more
variability in growth rate and parasitemia. They reached as high as 35 – 40% parasitemia without
showing any symptoms. These results clearly indicate that TrxL-1 is not essential in blood stage
development. However, the variability in TrxL-1KO parasitemia made phenotypic analysis
difficult as the data does not conclusively show that the TrxL-1KO parasites grow at a
significantly different growth rate than WT parasites.
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Trxl-1 Does Not Affect Morphology in Blood Stages
Because TrxL-1 could be potentially affecting the shape of the parasite, I examined
parasite morphology during the blood stages. I did not find any discernable differences between
the WT and TrxL-1KO parasites in any of the blood stages including merozoites, trophozoites,
schizonts, and gametocytes. A comparison of the WT and TrxL1-KO parasites is shown in
Figure 14.
Trxl-1 is Involved in Mosquito Stage Development
Next, I expanded my investigation of the potential phenotype to the mosquito stages of
development. Specifically, I examined the maturation of ookinetes within the mosquito midgut
over the course of 24 hours. To better describe the development of the ookinetes, I used
previously establishing maturation stages (Sinden et al. 2004) (Figure 15).
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Five to eight day old mosquitoes were allowed to feed on WT or TrxL-1KO infected
mice for 15 minutes. 12, 18, and 24 hours post infectious blood meal (PIBM), I dissected and
smeared five bloodfed mosquito midguts from each cohort. I selected 12 hours PIBM as my first
time point because the maturity level prior to this point could not be determined via light
microscopy. Data was collected from three independent feeds with independent cohorts of
mosquitoes and mice. The relative number of mature ookinetes was quantified for each dissected
mosquito midgut at each time point. The percentage of mature TrxL-1KO ookinetes was
compared with the percentage of mature WT ookinetes (Figure 16).

Compared to WT ookinetes, the data shows a significant reduction in the number of
mature TrxL-1KO ookinetes. I found that 12 hours PIBM, 76% of the wild type (WT) ookinetes
were fully developed, while only 30% of the TrxL-1KO ookinetes were mature. At 18 hours
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PIBM, 80% of WT ookinetes being mature, in comparison to 20% of the TrxL-1KO ookinetes
being fully developed. By 24 hours, almost 100% of WT ookinetes were found to be mature
while only 65% of TrxL-1 ookinetes were mature. The growth delay seen in the TrxL-1KO
ookinetes indicates that trxl-1 does play a role in the mosquito stage development.

To determine whether the TrxL-1KO ookinetes could continue to develop in the
mosquito (see Figure 1), I dissected midguts on day 9 and day 15 to examine oocyst formation
and removed salivary glands on day 21 to detect sporozoite formation. To visualize the oocysts, I
stained the dissected midguts with mercurochrome and viewed them under 400X magnification.
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I found that TrxL-1KO ookinetes were able to traverse the midgut lining and develop into
oocysts (Figure 17A). To visualize the sporozoites, the salivary glands were dissected, crushed
under the pressure of a coverslip, and viewed under 400X magnification. I found that the TrxL1KO parasites successfully developed into sporozoites as I was able to observe them flowing out
of the salivary glands (Figure 17B).
Once TrxL-1KO salivary gland sporozoites were confirmed, the infected mosquitoes
were allowed to feed on naïve mice to determine whether the TrxL-1KO parasites could infect
the mice and complete the life cycle. Twelve days post infectious feed, I found blood stage
parasites in the mice, confirming that the TrxL-1KO sporozoites were infectious to hepatocytes
and completed the life cycle.
TrxL-1 Specifically Affects Ookinete Development and Morphology
Because I hypothesized that TrxL-1 is involved in maintaining the shape of the parasite, I
next examined the morphology of the ookinetes under light microscopy and immunofluorescence
microscopy.
For light microscopy, ookinetes were smeared on slides and processed as previously
described in the materials and methods. In the smears, I found that many TrxL-1KO ookinetes
from both the midguts and cultures possessed distinct morphological deformities (Figure 18).
Compared to the midgut WT ookinetes (Figure 18A), some of the TrxL-1KO ookinetes were not
able to maintain their characteristic banana-shape while others could not elongate at all (Figure
18B). In the cultures, I also found that many TrxL-1KO ookinetes appeared to be either deflated
with particularly thin portions of the membrane or overinflated with large, bulbous protrusions
(Figure 18D).
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To determine if these morphological deformities are due to the destabilization of
microtubules, I used immunofluorescence to visualize the organization of microtubules in the
ookinetes. To this end, I set up mosquito feeds and ookinete cultures with WT and TrxL-1KO
parasites and prepared them for immunofluorescence labeling as detailed in the methods and
materials. I co-labeled the parasites with anti-PbTrx-1 antibodies and anti-𝛼-tubulin antibodies
graciously provided by Dr. Jennifer Mierisch. The tubulin antibodies localize specifically to the
periphery of the cell as they label the microtubules. Our lab has previously shown that
thioredoxin-1 (Trx-1) is a ubiquitously expressed protein in the cytosol of all P. berghei stages
(Turturice et al. 2013). I therefore used anti-PbTrx-1 antibodies to mark Thioredoxin-1 as a
cytosolic control. Parasites were imaged using confocal microscopy. To image the surface and
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middle sections of the ookinete, separate slices of the parasites were captured via scanning
through the sample.

The WT ookinetes showed distinct staining of tubulin localizing to the periphery of the
cell while Trx-1 was observed throughout the whole cell (Figure 19). The TrxL-1KO ookinetes
also displayed anti-PbTrx-1 staining throughout the entire length of the ookinete. However,
unlike the WT ookinetes, the TrxL-1KO ookinetes did not show distinct staining of tubulin on
the periphery (Figure 20).

44
In the middle and surface cross sections, tubulin was also stained throughout the whole
cell. Interestingly, the strong staining throughout the middle section suggested that most of the
tubulin in the ookinete was cytosolic. I did not find any stained ookinetes from the TrxL-1KO
midguts or 24-hour culture slides. Although more imaging is required, there is a strong indication
that the stability of the microtubules is affected by the loss of TrxL-1.
Disruption of spm-1 in P. berghei
In parallel with the phenotypic analysis of the TrxL-1KO parasites, I was also working on
the construct to delete the spm-1 gene (Figure 21). I generated a spm-1 specific TS using
Geneious as previously described for trxl-1. Because of the previous cloning problems with the
small 20 bp TS oligonucleotide, I instead engineered the spm-1 TS into primers so that it will be
integrated directly into the sgRNA scaffold on pBC. I used pBC as the DNA template and cloned
the resulting TS-sgRNA amplicon into pGEM. I then cloned the spm-1 TS-sgRNA into pBC.

To generate the homology construct, I used PCR to amplify the 5’ HA and 3’ HA of spm1. I then cloned the two homology arms into a separate vector as previously described for trxl-1.
I named the resulting SPM-1KO plasmid pBCS for plasmid for P. berghei CRISPR/Cas9
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mediated SPM-1KO (Figure 22). pBCS was transfected into PbWT schizonts and injected into
naïve mice. Transgenic parasites were selected for using pyr. Drug resistant parasites were
detected in the blood eight days post injection. The genomic DNA was extracted from five
separate transgenic parasite populations.

Verification of Cas9-mediated Gene Deletion of spm-1
To detect successful spm-1 deletion, initial PCR analysis was conducted using primers
specific to the 5’ HA and 3’ HA of spm-1 (Figure 23). The DNA templates used were: WT
gDNA, five SPM-1KO (KO1-KO5) gDNA samples, pBCS, and a no template control (NTC). As
expected, the WT gDNA generated an amplicon around 2.0 kb. Other than primer dimers, no
amplification was observed in the NTC. Because pBCS contains the homology construct for
spm-1, pBCS was used as a control to detect the expected amplicon size of the spm-1 deletion.
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Three of the SPM-1KO samples (KO1, KO2, and KO5) resulted in no amplification. Two KO
samples (KO3 and KO4) resulted in the amplification of the gDNA samples. KO3 showed a
band around 2.0 kb which indicates that there was no gene deletion in that sample. Only one of
the samples (KO4) contained a 1.0 kb band which indicates successful gene knockout. The KO4
sample also showed two additional bands around 1.5 and 2.0 kb indicating a mixed population.
Because KO4 showed gene deletion, this population was selected for cloning in order to generate
a SPM-1KO clonal line. Once cloned, additional primers for the gene disrupter and outside of the
5’ and 3’ HA on pBCS must be used in order to verify complete spm-1 knockout.
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Initial Analysis of SPM-1KO Parasites in Blood Stages
Once I confirmed the deletion of spm-1, I examined the parasites in the blood stages of
development. Similar to the TrxL-1KO, I found that the SPM-1KO parasites were able to
successfully infect the mice. The SPM-1KO infected mice reached parasitemias as high as 60%
and did not show any symptoms. These results show that spm-1 is not essential for blood stage
development. In contrast to the TrxL-1KO parasites, I found that there are morphological
deformities in the SPM-1KO schizonts (Figure 24). In comparison to the WT schizonts that
contain eight to twelve merozoites per cell (Figure 24 A), a portion of the SPM-1KO schizonts
only contain four to eight merozoites (Figure 24 B). Additionally, the merozoites within each of
the SPM-1KO schizonts appear to be more scattered and less organized than in the WT
schizonts.

CHAPTER IV
DISCUSSION
The purpose of this thesis was to establish the CRISPR/Cas9 gene editing system in P.
berghei and use it to investigate the function of two novel Plasmodium genes, trxl-1 and spm-1.
Genetic manipulation of Plasmodium remains a challenge as most methods are time consuming,
inefficient, and expensive (Straimer et al. 2012; Wu et al. 1996). The CRISPR/Cas9 system
represents an opportunity to reduce the cost and increase efficiency of genomic editing in the
prominent mouse model parasite P. berghei.
In this study, I established the CRISPR/Cas9 system in P. berghei and successfully edited
the genome resulting in the generation of two gene KO parasite lines, TrxL-1KO and SPM-1KO.
I found that trxl-1 is not an essential gene and is involved in ookinete development within the
mosquito midgut. Additionally, I found that the loss of spm-1 is not lethal in asexual stages, but
appears to be important for schizogony and gametocytogenesis in the malaria parasite.
The establishment of the CRISPR/Cas9 system increases our ability to manipulate the P.
berghei genome and subsequently advances the rate at which we can conduct functional studies.
As gene deletion is often the first approach to investigating gene function, I used CRISPR/Cas9
to knockout my genes of interest. Traditional gene knockout methods rely on the transfection of
a plasmid, containing a drug resistance cassette, and simple homologous recombination with the
genome to replace a targeted gene (Wu et al. 1996). This technique requires months of drug
selection and cloning following transfection of the plasmid with highly variable success.
48
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In contrast, with the help of the CRISPR/Cas9 system, I generated KO parasite lines
within just two weeks following transfection of the KO plasmids. Moreover, the resulting KO
parasite lines did not require months of constant drug pressure because CRISPR/Cas9 produces a
stable, targeted deletion and a quick, effective integration of the gene disrupter sequence. In
comparison to other studies that used CRISPR/Cas9, such as the editing of the P. falciparum
genome that required co-transfection of two plasmids (Wagner et al. 2014), I generated each
parasite line with the transfection of one plasmid. Using a single plasmid greatly increased the
efficiency of the generation of transgenic parasites, which subsequently improved the chance of
successful Cas9-mediated gene KO.
The first gene I knocked out was trxl-1. As the TrxL-1KO parasites successfully infected
and reproduced within the mouse blood and mosquito stages, I determined that trxl-1 is not an
essential gene. In the blood stages, I did not detect any TrxL-1KO growth phenotype, and there
were no observable differences in TrxL-1KO parasite morphology when compared to WT
parasites. These findings are comparable to the data from T. gondii as the researchers also did not
detect a growth phenotype in the TgTrxL-1 knockout parasites (Liu et al., 2013). Interestingly, I
found that although trxl-1 is dispensable for P. berghei, the knockout parasites seem to become
less virulent as infected mice tolerated a much higher parasitemia, at times up to 45%.
Additionally, many of the infected mice did not show any signs of illness that would be
expected at such high parasitemia. The functional significance of this loss of virulence remains
unknown and would be an interesting area to pursue in the future. One possible explanation is
that the TrxL-1KO parasites do not illicit an immune response that is as strong as it is during WT
P. berghei infection. To test for this, we can begin by checking the TrxL-1KO blood smears for
activated white blood cells.

50
Supporting my hypothesis that trxl-1 is involved in mosquito stage development, I found
that the growth of TrxL-1KO ookinetes is significantly delayed when compared to the WT
ookinetes. At 18 hours PIBM, I found that approximately 80% of TrxL-1KO ookinetes were
immature. I also observed distinct morphological deformities in the TrxL-1KO ookinetes when
compared to WT. The normal banana-like shape of the ookinetes is not retained and in some
cases, not established at all. As the subpellicular microtubules are known to support the
parasite’s shape (Baum et al.2006) and the T. gondii trxl-1 homolog showed an interaction with
microtubules, trxl-1 could be playing a role in the stabilization of the microtubules in the
development of Plasmodium ookinetes.
A subset of TrxL-1KO ookinetes were capable of maturing into their proper shape and
successfully infecting the mosquito. One explanation is that there could be a compensatory
mechanism allowing these ookinetes to function normally. In T. gondii, it was found that the
TgTrxL-1 protein is part of a microtubule associated protein complex that consists of the
subpellicular microtubule protein 1 (TgSPM-1), thioredoxin-like protein 2 (TgTrxL-2), and other
novel TrxL1-associating proteins, TgTLAP-1 and TgTLAP-2 (Liu et al., 2013). However, a
screen of the P. berghei genome revealed that Plasmodium lacks a trxl-2 homolog. Homologs for
SPM-1, TLAP-1, and TLAP-2 are present in the rodent parasite and it is possible that they have
the capacity to compensate for the loss of trxl-1. On the other hand, since T. gondii does not
require an insect vector, the conditions that control microtubule stability and regulation may be
different. Because Plasmodium parasites are exposed to the harsh conditions of the mosquito
midgut, I would expect the proteins lining and controlling regulation of the subpellicular
microtubules to play a more important role in the malaria parasite than in Toxoplasma.
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A closer inspection of the Plasmodium microtubules via immunofluorescence revealed
that the microtubules in the TrxL-1KO ookinetes appear to be less organized and are not clearly
localized to the periphery of the cell (Figure 25). This could compromise the overall bananashape of the maturing ookinete.

This suggests that the loss of trxl-1 prevents the localization of microtubules to the
periphery of the cell and consequently negatively affects ookinete elongation, shape formation,
and rate of development. While this data serves to initially characterize the molecular function of
TrxL-1, further investigation is necessary in order to confirm the effect on microtubule
stabilization and parasite biology. On top of additional immunofluorescence microscopy,
viewing the parasites under a higher resolution, such as electron microscopy, would provide a
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much more detailed look into the morphology and underlying cytoskeletal organization. Another
approach that we could use to confirm these findings is a trxl-1 gene rescue by providing the
parasites with a plasmid containing the functional trxl-1 gene. If normal ookinete development
and morphology is restored, we would confirm that the phenotype we have observed is due to the
loss of trxl-1.
In Toxoplasma, the TrxL-1 protein was shown to indirectly associate with the
subpellicular microtubules via an interaction with SPM-1 (Liu et al., 2013), which is why I
decided to knockout spm-1 in P. berghei. Similar to trxl-1, I found that spm-1 is not essential for
the development of the asexual blood stages in the mouse. However, my preliminary analysis of
the SPM-1KO parasites showed that the SPM1-KO schizonts appear to have morphological
differences when compared to WT. For example, no distinct equally sized merozoites can be
identified and the number of merozoites is very low when compared to WT parasites.
Furthermore, very few mature gametocytes have been identified in the blood smears of the SPM1KO infected mice. These initial observations are currently being verified and quantified in our
lab.
Interestingly, if spm-1 is confirmed to be involved in schizogony or gametocytogenesis,
the overall effects of the SPM-1KO may be more detrimental than the TrxL-1KO. During
schizogony, the pellicle of the merozoites is supported by the underlying subpellicular
microtubules. Because spm-1 may potentially play a role in the stabilization of these
subpellicular microtubules, pellicle formation may be negatively affected by the loss of spm-1.
On the other hand, if gametocytogenesis is negatively affected, I would expect a more severe
phenotype in early mosquito stages. Microtubule associated proteins, such as the STOP
Axonemal protein (SAXO-1) in the flagellated, protozoan parasite Trypanosoma brucei

53
(Dacheux et al., 2012), have been shown to stabilize microtubules by conferring cold-resistance.
This study also demonstrated that TbSAXO-1 is involved in flagellum motility. As Plasmodium
experiences a temperature drop in the mosquito vector and requires the production of
exflagellating gametocytes, spm-1 may be functioning in a similar way to TbSAXO-1. Without
the exflagellation of gametocytes, there would be no fertilization and thus no ookinetes. If the
ookinetes cannot develop, the life cycle ends in the mosquito, effectively blocking transmission
to the next host. As additional analyses are required to characterize this phenotype, members of
my lab are eagerly continuing to investigate the role of spm-1 in all stages of parasite
development.
Beyond discovering the cellular function of trxl-1 and spm-1, this thesis sheds light on
the regulation of the subpellicular microtubules. In recent years, the thioredoxin system has been
implicated in the redox regulation of important cellular pathways and structures. Certain changes
in the redox potential of the cell, such as the production of ROS, can influence the state of
cellular structures, including microtubules and flagella (Aksenova et al., 2001; Wakabayashi and
King, 2006).
Biochemical characterization of both TrxL-1 and SPM-1 proteins in our lab revealed that
they are redox active and that each is efficiently reduced by the thioredoxin system. An
intriguing possibility is that the association of TrxL-1 with its target proteins, such as SPM-1,
may be redox based. In light of these findings, it is possible that in Plasmodium, TrxL-1 and/or
SPM-1 represent a direct link between the cellular redox regulatory system and the cytoskeleton,
in this case the microtubules. I have included a hypothetical model representing the connection
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between the Trx-mediated redox homeostasis of the cell and microtubule stability via the
interactions between TrxL-1 and SPM-1 (Figure 26).

With this study, I am the first to establish the CRISPR/Cas9 system in P. berghei. I
successfully adapted this system to modify the P. berghei genome and generated two gene KO
parasite lines with high efficiency (100% gene deletion for each trxl-1 and spm-1.) The
functional characterization of TrxL-1 revealed that it plays a role in parasite development in the
mosquito vector, specifically in the generation and maintenance of the banana-like ookinete
shape. We have shown that TrxL-1 is potentially regulated by the Trx system and is involved in
the stabilization of the subpellicular microtubules via SPM-1. Overall, this study contributes to
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our fundamental understanding of the regulation of microtubules and reveals a potential
mechanism for parasite development and survival in the mosquito vector.
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